Status:
COMPLETED
The NeXT Study; The Netherlands XTC Toxicity Study
Lead Sponsor:
UMC Utrecht
Collaborating Sponsors:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
University of Amsterdam, Bonger Institute of Criminology
Conditions:
Ecstasy (Drug)
N-Methyl-3,4-Methylenedioxymethamphetamine
Eligibility:
All Genders
18-35 years
Brief Summary
The purpose of this study is to investigate the possible neurotoxic effects of the party-drug Ecstasy (MDMA)on brain and brain function in humans. Main research questions concern the causality, course...
Detailed Description
The study aims to investigate the causality, course and clinical relevance of the observed neurotoxicity in het human brain among users of the popular recreational drug 3,4-methylenedioxymethamphetami...
Eligibility Criteria
Inclusion
- between 18 - 35 years of age
Exclusion
- severe medical or neuropsychiatric illness
- use of prescribed psychotropic medications such as SSRI's
- use of intravenous drugs
- pregnancy
- contra-indications for MRI investigation
Key Trial Info
Start Date :
April 1 2002
Trial Type :
OBSERVATIONAL
End Date :
July 1 2005
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT00235768
Start Date
April 1 2002
End Date
July 1 2005
Last Update
October 10 2005
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Bonger Institute of Criminology
Amsterdam, North Holland, Netherlands, 1000 BA
2
Academic Medical Center Amsterdam
Amsterdam, North Holland, Netherlands, 1100 DD
3
University Medical Center Utrecht
Utrecht, Utrecht, Netherlands, 3584 CX